Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors
- 1 August 1994
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 260 (2-3) , 251-255
- https://doi.org/10.1016/0014-2999(94)90346-8
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Pindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake InhibitorsArchives of General Psychiatry, 1994
- Neurochemical profile of the selective and silent 5-HT1A receptor antagonist WAY100135: an in vivo microdialysis studyEuropean Journal of Pharmacology, 1993
- 5-HT and antidepressants: new views from microdialysis studiesTrends in Pharmacological Sciences, 1993
- Serotonin 5‐HT1A Autoreceptor Blockade Potentiates the Ability of the 5‐HT Reuptake Inhibitor Citalopram to Increase Nerve Terminal Output of 5‐HT In Vivo: A Microdialysis StudyJournal of Neurochemistry, 1993
- Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortexBrain Research, 1992
- Pharmacological characterization of 8‐OH‐DPAT‐induced inhibition of rat hippocampal 5‐HT release in vivo as measured by microdialysisBritish Journal of Pharmacology, 1989
- Modifications of the Serotonin System by Antidepressant TreatmentsJournal of Clinical Psychopharmacology, 1987